Evidence map›Paper›PMID 40871350›Full record

ArticleMicroorganisms2025

Optimizing Scaled up Production and Purification of Recombinant Hydrophobin HFBI in

Mason A Kinkeade, Aurora L Pagan, Bryan W Berger

Abstract read
In one paragraph

Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mason A KinkeadeDepartment of Chemical Engineering, University of Virginia, Charlottesville, VA 22903, USA.
Aurora L PaganGermanna Community College, Fredericksburg, VA 22408, USA.
Bryan W BergerGermanna Community College, Fredericksburg, VA 22408, USA.ORCID 0000-0002-6135-8677

Funding

U.S. National Science Foundation 2211060
6 · The paper itself

Abstract

Hydrophobins are small, surface-active protein biosurfactants secreted by filamentous fungi with potential applications in industries such as pharmaceuticals, sanitation, and biomaterials. Additionally, hydrophobins are known to stabilize enzymatic processing of biomass for improved catalytic efficiency. In this study,

Indexed as

biosurfactantCapto MMC ImpResHFBIhydrophobinimmobilized metal affinity chromatographymultimodal chromatographyPichia pastorissize exclusion chromatography

Identifiers

PMID40871350
PMCPMC12388604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.